Fibroblast growth factor receptor (FGFR) inhibitors: A review of a novel therapeutic class.
J Oncol Pharm Pract. 2021 Apr;27(3):702-710. doi: 10.1177/1078155220983425. Epub 2020 Dec 29.
J Oncol Pharm Pract. 2021.
PMID: 33375902
Review.